Maternal obesity - a risk factor for metabolic syndrome in children

Melinda Morea1, Nicolae Miu1, Vicenţiu Florin Morea2

  • 1Pediatric Emergency County Hospital Cluj-Napoca, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Clujul Medical (1957)
|November 4, 2015
PubMed

Insights

Maternal pre-pregnancy overweight or obesity is a significant risk factor for metabolic syndrome (MS) in children. This highlights the importance of the perinatal period for future research and prevention strategies.

Area of Science:

  • Pediatrics
  • Public Health
  • Endocrinology

Background:

  • Metabolic syndrome (MS) in children is a growing concern.
  • Maternal pre-pregnancy nutritional status is a potential contributing factor to childhood MS.

Purpose of the Study:

  • To investigate the association between maternal pre-pregnancy Body Mass Index (BMI) and the prevalence of MS in offspring.
  • To identify potential risk factors for MS in children.

Main Methods:

  • A study involving 180 children aged 6-19 years.
  • Maternal pre-pregnancy BMI was categorized (normal, overweight, obese).
  • Childhood MS was diagnosed using IDF criteria or age/gender-specific cut-offs; physical and laboratory assessments were conducted.

Main Results:

  • Overweight and obese children had higher rates of MS compared to normal-weight children.
  • Maternal pre-pregnancy overweight and obesity were significantly associated with offspring MS in both genders and specific age groups.
  • A high percentage of mothers were normal weight (69.44%), but overweight (24.44%) and obese (6.11%) mothers also contributed to offspring MS.

Conclusions:

  • Pre-pregnancy maternal overweight/obesity is a risk factor for childhood MS.
  • Variability in MS definitions and cut-off values complicates cross-study comparisons.
  • The perinatal period is a critical focus for future research and prevention of childhood MS.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.4K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.7K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.5K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
282